CTCL represents a heterogeneous group of disorders, including subtypes such as mycosis fungoides (MF), Sézary syndrome (SS) and CD30+ lymphoproliferative disorders (LPDs). This evidence concerns the gene TNFRSF8 and primary cutaneous T-cell non-Hodgkin lymphoma.